Remdesivir Recent News

FDA Approves Gilead's Remdesivir For Treatment Of Hospitalized COVID-19 Patients
Gilead's Remdesivir Ineffective In COVID-19 Patients, WHO Study Finds
Eli Lilly Halts Antibody COVID-19 Trial
Gilead's Veklury Study Shows Faster COVID-19 Recovery, Reduced Disease Progression, Mortality
Ligand: The Small Cap Powering Gilead's Remdesivir
Trump To Depart Walter Reed, Says 'Don't Be Afraid' Of COVID-19 As Virus-Related Death Toll Nears 210K In US
PreMarket Prep Stock Of The Day: Gilead Sciences
Trump's Doc Says President Fever-Free, Taking COVID-19 Treatment Remdesivir At Walter Reed
Gilead, Pfizer, Eli Lilly CEOs On COVID-19 Treatments, Vaccine Development
Gilead Seeks Full FDA Approval Of Its Remdesivir Drug For Coronavirus
Pfizer, Gilead Strike Multiyear Partnership To Manufacture COVID-19 Drug Remdesivir
Gilead Analysts Downplay Q2 Miss Amid Remdesivir's COVID-19 Opportunity
Ex-FDA Commissioner Gottlieb On Whether Coronavirus Vaccine Will Bring Return To Normal
Credit Suisse Upgrades Gilead On Remdesivir Commercial Opportunity
BofA On 3 Coronavirus Vaccine Frontrunners, The Remdesivir Opportunity And Antibodies
Gilead's Remdesivir Data Shows Improved Clinical Recovery, Reduced Death Rate
Gilead Announces Pricing Of Coronavirus Treatment Remdesivir: 'We Believe All Patients Will Have Access'
FDA Withdraws Emergency Use Authorization For Hydroxychloroquine
Here's How Large Option Traders Are Playing Gilead Following Latest COVID-19 Trial Data
Gilead Analyst: Coronavirus Drug, Arcus Collaboration Make Biopharma A Buy
Pharma Large And Mid-Caps Race Against COVID-19
Gilead Falls On Mixed Results From Late-Stage Remdesivir Study In Moderate COVID-19
UK Clears Gilead's Remdesivir For Some Coronavirus Patients